TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Actelion Pharmaceuticals Sverige AB
Closing information (x1000 DKK)
Closing information | 2018/12 | 2017/12 | 2016/12 |
Turnover | 188,221 | 188,827 | 174,069 |
Financial expenses | 1,528 | 2,358 | 30 |
Earnings before taxes | 7,683 | 12,534 | 7,859 |
EBITDA | 7,642 | 14,128 | 4,697 |
Total assets | 133,998 | 121,941 | 106,544 |
Current assets | 133,814 | 121,433 | 105,842 |
Current liabilities | 95,178 | 84,872 | 77,124 |
Equity capital | 38,820 | 37,068 | 27,156 |
- share capital | 727 | 756 | 777 |
Employees (average) | 29 | 28 | 29 |
Financial ratios
Fiscal year | 2018/12 | 2017/12 | 2016/12 |
Solvency | 29.0% | 30.4% | 25.5% |
Turnover per employee | 6,490 | 6,744 | 6,002 |
Profit as a percentage of turnover | 4.1% | 6.6% | 4.5% |
Return on assets (ROA) | 6.9% | 12.2% | 7.4% |
Current ratio | 140.6% | 143.1% | 137.2% |
Return on equity (ROE) | 19.8% | 33.8% | 28.9% |
Change turnover | 6,666 | 19,517 | 6,152 |
Change turnover % | 4% | 12% | 4% |
Chg. No. of employees | 1 | -1 | 1 |
Chg. No. of employees % | 4% | -3% | 4% |
Total value of public sale
Fiscal year | 2018/12 | 2017/12 | 2016/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.